Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
|
|
HAEMONETICS CORP (HAE)
|
Add to portfolio |
|
|
|
| Price: |
$54.70
| | Metrics |
| OS: |
50.7
|
M
| |
|
|
| Market cap: |
$2.77
|
B
| |
|
|
|
Net debt:
|
$479
|
M
| |
2.2
|
x Debt/EBITDA
|
|
EV:
|
$3.25
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$216
|
M
| |
15.1
|
x EV/EBITDA
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Apr-02-22 | Apr-03-21 | Mar-28-20 | Mar-30-19 | Mar-31-18 | Apr-01-17 | Apr-02-16 | Mar-28-15 |
| Revenues | 993.2 | 870.5 | 988.5 | 967.6 | 903.9 | 886.1 | 908.8 | 910.4 |
| Revenue growth | 14.1% | -11.9% | 2.2% | 7.0% | 2.0% | -2.5% | -0.2% | -3.0% |
| Cost of goods sold | 487.7 | 472.6 | 504.0 | 550.0 | 492.0 | 507.6 | 502.9 | 476.0 |
| Gross profit | 505.5 | 397.8 | 484.5 | 417.5 | 411.9 | 378.5 | 405.9 | 434.4 |
| Gross margin | 50.9% | 45.7% | 49.0% | 43.2% | 45.6% | 42.7% | 44.7% | 47.7% |
| Selling, general and administrative | 339.6 | 274.2 | 282.0 | 273.5 | 316.5 | 301.7 | 317.2 | 337.2 |
| Research and development | 46.8 | 32.9 | 30.9 | 35.7 | 39.2 | 37.6 | 45.0 | 54.2 |
| EBITA | 128.3 | 99.2 | 180.1 | 122.4 | 137.6 | 76.4 | 103.0 | 74.0 |
| EBITA margin | 12.9% | 11.4% | 18.2% | 12.7% | 15.2% | 8.6% | 11.3% | 8.1% |
| Amortization of intangibles | 56.6 | 41.2 | 34.2 | 24.8 | 31.9 | 37.2 | 59.3 | 33.5 |
| EBIT | 71.7 | 58.0 | 145.9 | 97.6 | 105.7 | 39.2 | 43.7 | 40.5 |
| EBIT margin | 7.2% | 6.7% | 14.8% | 10.1% | 11.7% | 4.4% | 4.8% | 4.5% |
| Pre-tax income | 63.6 | 72.9 | 87.2 | 73.6 | 59.6 | -27.5 | -53.4 | 31.2 |
| Income taxes | 20.3 | -6.6 | 10.6 | 18.6 | 14.1 | -1.2 | 2.2 | 14.3 |
| Tax rate | 31.8% | | 12.2% | 25.3% | 23.6% | 4.4% | | 45.8% |
| Net income | 43.4 | 79.5 | 76.5 | 55.0 | 45.6 | -26.3 | -55.6 | 16.9 |
| Net margin | 4.4% | 9.1% | 7.7% | 5.7% | 5.0% | -3.0% | -6.1% | 1.9% |
| |
| Diluted EPS | $0.84 | $1.55 | $1.48 | $1.04 | $0.85 | ($0.51) | ($1.09) | $0.32 |
| Shares outstanding (diluted) | 51.4 | 51.3 | 51.8 | 52.9 | 53.5 | 51.5 | 50.9 | 52.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|